192 related articles for article (PubMed ID: 28981599)
1. DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel.
Yang X; Liu Y; Li W; Li A; Sun Q
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):899-906. PubMed ID: 28981599
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
Wang K; Zhu X; Zhang K; Zhu L; Zhou F
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):804-9. PubMed ID: 27521795
[TBL] [Abstract][Full Text] [Related]
3. Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma.
Wang R; Huang J; Feng B; De W; Chen L
Mol Med; 2012 Jul; 18(1):874-86. PubMed ID: 22460125
[TBL] [Abstract][Full Text] [Related]
4. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Feng B; Huang GC; Wang R; Chen LB; De W
Mol Cancer Res; 2013 Jul; 11(7):699-713. PubMed ID: 23562878
[TBL] [Abstract][Full Text] [Related]
5. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
[TBL] [Abstract][Full Text] [Related]
8. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells.
He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X
Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.
Ren J; Chen Y; Song H; Chen L; Wang R
J Cell Biochem; 2013 Jun; 114(6):1395-403. PubMed ID: 23255418
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell.
Tao L; Huang G; Chen Y; Chen L
Cancer Biother Radiopharm; 2015 Mar; 30(2):100-6. PubMed ID: 25760729
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor.
Chen S; Wang Q; Zhou XM; Zhu JP; Li T; Huang M
Mol Med Rep; 2016 Jul; 14(1):949-54. PubMed ID: 27221512
[TBL] [Abstract][Full Text] [Related]
12. MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma.
Pan B; Feng B; Chen Y; Huang G; Wang R; Chen L; Song H
Oncotarget; 2015 Oct; 6(32):32805-20. PubMed ID: 26416454
[TBL] [Abstract][Full Text] [Related]
13. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
Wang F; Mao Y; You Q; Hua D; Cai D
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation.
Qin S; Zhang B; Xiao G; Sun X; Li G; Huang G; Gao X; Li X; Wang H; Yang C; Ren H
Tumour Biol; 2016 Oct; 37(10):13509-13520. PubMed ID: 27465556
[TBL] [Abstract][Full Text] [Related]
15. Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway.
Wang Z; Ma LJ; Kang Y; Li X; Zhang XJ
Oncol Rep; 2015 Mar; 33(3):1097-106. PubMed ID: 25573172
[TBL] [Abstract][Full Text] [Related]
16. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
17. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.
Pan B; Chen D; Huang J; Wang R; Feng B; Song H; Chen L
Mol Cancer; 2014 Jul; 13():165. PubMed ID: 24996221
[TBL] [Abstract][Full Text] [Related]
18. Apatinib sensitizes chemoresistant NSCLC cells to doxetaxel via regulating autophagy and enhances the therapeutic efficacy in advanced and refractory/recurrent NSCLC.
Hu R; Li T; Hui K; Chen Z; Wang N; Wu X; Ge L; Zhou L
Mol Med Rep; 2020 Nov; 22(5):3935-3943. PubMed ID: 32901884
[TBL] [Abstract][Full Text] [Related]
19. The effects of Dickkopf-4 on the proliferation, differentiation, and apoptosis of osteoblasts.
Hiramitsu S; Terauchi M; Kubota T
Endocrinology; 2013 Dec; 154(12):4618-26. PubMed ID: 24105477
[TBL] [Abstract][Full Text] [Related]
20. Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis.
Hwang KE; Park DS; Kim YS; Kim BR; Park SN; Lee MK; Park SH; Yoon KH; Jeong ET; Kim HR
Int J Oncol; 2013 Jul; 43(1):72-8. PubMed ID: 23615915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
